Pro-Dex, Inc. is competing in the medical-surgical products market and was rated and analyzed by MarketBeat on September 1, 2026.
1 report, 1 independent
Updated Sep 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pro-Dex, Inc. is competing in the medical-surgical products market and was rated and analyzed by MarketBeat on September 1, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
Related events
- MarketBeat uses for analyst ratings and competes in the medical device market, involving Teleflex and Vasamed.
- MarketBeat is providing analyst ratings and tracking the competitive landscape between healthcare companies Pfizer and Lyra Therapeutics.
- MarketBeat summarized current ratings and price targets for Arcturus Therapeutics.
- MarketBeat provided analyst ratings and targets for small-cap healthcare companies Emergent BioSolutions and Entrada Therapeutics.
- MarketBeat is providing consensus price targets and analyst recommendations for consumer staples companies, including JBS S.A. and Inspire Veterinary Partners.